摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(4-溴苯基)甲基]丁胺 | 60509-40-2

中文名称
N-[(4-溴苯基)甲基]丁胺
中文别名
(4-溴苄基)丁基-1-胺;(R)-丁酸缩水甘油酯
英文名称
N-(4-bromobenzyl)butan-1-amine
英文别名
(4-bromo-benzyl)(butyl)amine;(4-Brom-benzyl)-butyl-amin;Benzenemethanamine, 4-bromo-N-butyl-;N-[(4-bromophenyl)methyl]butan-1-amine
N-[(4-溴苯基)甲基]丁胺化学式
CAS
60509-40-2
化学式
C11H16BrN
mdl
MFCD07409923
分子量
242.159
InChiKey
MCNOIXPMJHKLAK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    13
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.454
  • 拓扑面积:
    12
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2921499090

SDS

SDS:a87c1d5e3fa1199379f096d1ae65501c
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    三乙基硼N-[(4-溴苯基)甲基]丁胺(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloridecaesium carbonate 作用下, 以 四氢呋喃 为溶剂, 以92%的产率得到Butyl[(4-ethylphenyl)methyl]amine
    参考文献:
    名称:
    在温和的非水条件下,三烷基硼烷与芳族溴化物的直接B-烷基铃木-Miyaura交叉偶联存在未掩盖的酸性或基本功能以及对碱不稳定的保护作用
    摘要:
    Abstractmagnified imageAn efficient and chemoselective palladium‐catalyzed direct B‐alkyl Suzuki–Miyaura cross‐coupling of trialkylboranes with diversely functionalized aryl bromides is described. A wide variety of unmasked acidic or basic functions are tolerated. The mild non‐aqueous conditions are compatible with aldehydes, ketones, nitriles, chloro substitution as well as base‐labile phenolic Piv and TBS protecting groups. The anhydrous conditions were found to be advantageous for aryl bromide substrates. A potent CEPT inhibitor was efficiently synthesised using this protocol.
    DOI:
    10.1002/adsc.200800630
  • 作为产物:
    描述:
    N-(4-bromobenzylidene)butan-1-amine 在 silica gel 、 C25H52N5NdSi4 作用下, 以 氯苯 为溶剂, 生成 N-[(4-溴苯基)甲基]丁胺
    参考文献:
    名称:
    2-N,N-二甲氨基-乙烯-亚氨基官能化吲哚配体稀土金属配合物的合成与表征及其对亚胺氢化硅烷化的催化活性
    摘要:
    2 - N , N-二甲基氨基-亚乙基-亚氨基官能化吲哚前配体2-(Me 2 NCH 2 CH 2 N = CH)C 8 H 5 NH (H L ) 与[(Me 3 Si) 2 N]的反应3 RE(μ-Cl)Li(THF) 3在甲苯中得到一系列稀土金属氨基络合物 [κ 3 -( N , N , N )-2-(Me 2 NCH 2 CH 2 N = CH)C 8 H 5 N]RE[N(SiMe 3 )2 ] 2 (RE = Y ( 1a ), Nd ( 1b ), Sm ( 1c ), Gd ( 1d ), Dy ( 1e ), Er ( 1f ), 和 Yb ( 1g ))。H L与 [(Me 3 Si) 2 N] 3 Eu(μ-Cl)Li(THF) 3反应生成二聚体形式的铕(II)络合物[{(η 5 -μ-η 1 : η 1 :η 1 )-2-(Me 2 NCH 2 CH 2 N=CH )C
    DOI:
    10.1021/acs.organomet.2c00412
点击查看最新优质反应信息

文献信息

  • Palladium- and Nickel-Catalyzed Cross-Couplings of Unsaturated Halides Bearing Relatively Acidic Protons with Organozinc Reagents
    作者:Georg Manolikakes、Carmen Muñoz Hernandez、Matthias A. Schade、Albrecht Metzger、Paul Knochel
    DOI:10.1021/jo8015852
    日期:2008.11.7
    aryl, heteroaryl, alkyl, and benzylic zinc reagents were coupled with unsaturated aryl halides bearing an acidic NH or OH proton, using Pd(OAc)2 (1 mol %) and S-Phos (2 mol %) as catalyst without the need of protecting groups. A similar nickel-catalyzed reaction is described. The relative kinetic basicity of organozinc compounds as well as their stability toward acidic protons is also described.
    多种多官能芳基,杂芳基,烷基和苄基锌试剂与带有酸性NH或OH质子的不饱和芳基卤化物偶合,使用Pd(OAc)2(1 mol%)和S-Phos(2 mol%)作为不需要保护基的催化剂。描述了类似的镍催化反应。还描述了有机锌化合物的相对动力学碱性及其对酸性质子的稳定性。
  • Palladium-Catalyzed Carbonylative Synthesis of Isoindolinones from Benzylamines with TFBen as the CO Source
    作者:Lu-Yang Fu、Jun Ying、Xinxin Qi、Jin-Bao Peng、Xiao-Feng Wu
    DOI:10.1021/acs.joc.8b02862
    日期:2019.2.1
    A palladium-catalyzed C–H carbonylation of benzylamines for the synthesis of isoindolinone scaffolds has been developed. This protocol is conducted under gas-free conditions by using benzene-1,3,5-triyl triformate (TFBen) as a convenient CO surrogate, furnishing a variety of isoindolinone derivatives in moderate to high yields (up to 95%).
    已经开发了钯催化的苄胺的CH羰基化反应,用于合成异吲哚啉酮骨架。该方案是在无气体的条件下通过使用1,2,3,5-三甲酸三苯酯(TFBen)作为便利的一氧化碳替代物进行的,以中等至高收率(高达95%)提供各种异吲哚啉酮衍生物。
  • LINCOMYCIN DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT
    申请人:Wakiyama Yoshinari
    公开号:US20100210570A1
    公开(公告)日:2010-08-19
    An objective of the present invention is to provide compounds of formula (1) or their pharmacologically acceptable salts or solvates wherein A represents aryl; R 1 represents N-optionally substituted C 1-6 alkyl-N-optionally substituted C 1-6 alkylamino-C 1-6 alkyl; R 2 represents a hydrogen atom or optionally substituted C 1-6 alkyl; R 3 represents optionally substituted C 1-6 alkyl or C 3-6 cycloalkyl-C 1-4 alkyl; m is 1 to 3; n is 0; and p is 0 to 2. The compounds are novel lincomycin derivatives that have a potent activity against resistant Streptococcus pneumoniae, which have recently posed problems, in the treatment of infectious diseases. Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases.
    本发明的目标是提供以下化合物(1)或其药理学上可接受的盐或溶剂,其中A代表芳基;R1代表N-可选取代的C1-6烷基-N-可选取代的C1-6烷基氨基-C1-6烷基;R2代表氢原子或可选取代的C1-6烷基;R3代表可选取代的C1-6烷基或C3-6环烷基-C1-4烷基;m为1至3;n为0;p为0至2。这些化合物是新颖的林可霉素衍生物,对最近在感染性疾病治疗中引起问题的耐药性肺炎链球菌具有强效活性。此外,这些化合物可用作抗微生物药物,有助于预防或治疗细菌感染性疾病。
  • Benzimidazole derivatives and their use as a medicament
    申请人:Poitout Lydie
    公开号:US20090170922A1
    公开(公告)日:2009-07-02
    A subject of the present application is new benzimidazole derivatives of formula in which A, Y, R 1 , R 2 , R 3 and R 4 represent different variable groups. These products have an antagonist activity of GnRH (Gonadotropin-Releasing Hormone). The invention also relates to pharmaceutical compositions containing said products and their use for the preparation of a medicament.
    本申请的主题是公式中A、Y、R1、R2、R3和R4代表不同变量基团的新苯并咪唑衍生物。这些产物具有GnRH(促性腺激素释放激素)的拮抗活性。本发明还涉及含有所述产物的制药组合物及其用于制备药物的用途。
  • [EN] SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS<br/>[FR] INHIBITEURS SÉLECTIFS DE L'HISTONE DÉSACÉTYLASE 6
    申请人:THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOS
    公开号:WO2021263171A1
    公开(公告)日:2021-12-30
    The present disclosure provides methods, pharmaceutical compositions, and kits comprising histone deacetylase (HD AC) inhibitors of formula I, or a pharmaceutically acceptable salt thereof, wherein R1, R2, L1, L2, m, n, p, X, Y, and Z are as defined in the specification, including methods of increasing the sensitivity of cancer cells to the cytotoxic effects of radiotherapy and/or chemotherapy in a subject.
    本公开提供了一种方法、制药组合物和工具包,其中包括式I的组蛋白去乙酰化酶(HDAC)抑制剂或其药学上可接受的盐,其中R1、R2、L1、L2、m、n、p、X、Y和Z如规范中所定义,包括增加癌细胞对放疗和/或化疗的细胞毒性作用的敏感性方法。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐